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Abstract 
Rho GTPases are critical for actin cytoskeletal regulation, and alterations in their activity 
may contribute to altered cytoskeletal organization that characterizes many pathological 
conditions, including ischemia. G-protein activity is a function of the ratio of GTP-bound 
(active) to GDP-bound (inactive) protein, but the effect of altered energy metabolism on 
Rho protein activity has not been determined. We used antimycin A and substrate 
depletion to induce depletion of intracellular ATP and GTP in the kidney proximal tubule 
cell line LLC-PK10, and measured the activity of RhoA, Rac1 and Cdc42 using GTPase 
effector binding domains fused to glutathione S-transferase. RhoA activity decreased in 
parallel with the concentration of ATP and GTP during depletion so that by 60 minutes 
there was no detectable RhoA-GTP, and recovered rapidly when cells were returned to 
normal culture conditions. Dissociation of the membrane-actin linker ezrin, a target of 
RhoA signaling, from the cytoskeletal fraction paralleled the decrease in RhoA activity, 
and was augmented by treatment with the Rho kinase inhibitor Y27632. The activity of 
Cdc42 did not decrease significantly during depletion or recovery. Rac1 activity 
decreased moderately to a minimum at 30 minutes of depletion, but then increased from 
30-90 minutes of depletion, even as ATP and GTP levels continued to fall. Our data are 
consistent with a principal role for RhoA in cytoskeletal reorganization during ischemia, 
and demonstrate that the activity of Rho GTPases can be maintained even at low GTP 
concentrations.  
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Hallett, Dagher and Atkinson, 2003 
Rho Activity and Ischemia 
3
Introduction 
Rho family GTPases are members of the Ras superfamily of p21 G-proteins (25). 
They play a central role in regulating the organization and dynamics of the cytoskeleton, 
and thus integrate cell morphology and behavior with environmental signals and cellular 
physiology (6). The biological activities of small GTPases are regulated by their guanine 
nucleotide binding state (12). They interact with and activate their effectors when in the 
GTP-bound state and are inactive when the bound nucleotide is GDP, and in this way act 
as protein molecular switches. The position of the switch is set by the activity of 
antagonistic regulatory proteins, since the intrinsic GTPase rates and nucleotide 
dissociation rates for these proteins are slow. GTPase activating proteins (GAPs) 
stimulate nucleotide hydrolysis, thereby turning off the signal, whereas guanine 
nucleotide exchange factors (GEFs) stimulate GDP release and its replacement with GTP 
(the latter normally being the predominant guanine nucleotide in the cytoplasm) thus 
turning on signaling (7). However, these mechanisms, as they are commonly presumed to 
function, presuppose the nucleotide concentrations that prevail in normal healthy cells, 
but data are currently lacking on the effect of altered guanine nucleotide concentrations 
on p21 GTPase activity.  
Ischemia is a pathophysiological state that is characterized in part by poor tissue 
perfusion and subsequent anoxia, with inhibition of oxidative phosphorylation due to 
substrate depletion (13). Although ischemia is a complex multi-factorial process, many of 
its consequences result from, and can be recapitulated by, depletion of the normal 
intracellular concentration of ATP (3). Ischemic injury to the epithelial cells of the kidney 
proximal tubule is a factor in the initiation and progression of acute renal failure, and 
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typifies many of the features of ischemic injury in other cell types and organs. The 
normal architecture of the actin cytoskeleton is an early casualty of ischemic injury and 
ATP depletion, and this disruption directly results in impaired cell-cell and cell-substrate 
adhesion, loss of tight junction barrier function (3,17) and mixing of apical and 
basolateral transporters (30), with resultant impaired organ physiology and structure. 
There is a loss of actin from the apical microvilli, terminal web, cortical junctional 
complexes and stress fibers. This results in membrane blebbing, internalization and loss 
of apical microvilli (15,40). The loss of actin and villin from microvilli is coincident with 
abnormal perinuclear accumulation of F-actin (42) and an increase in the ratio of F- to G-
actin in the cell.  
The complexity and pervasiveness of the cytoskeletal alterations that are 
precipitated by ischemic injury indicate that they are probably the result of the combined 
effect of many different pathways. Perturbations of normal signaling pathways are 
probably a major factor in this aspect of injury, and in view of their critical role in 
cytoskeletal regulation, Rho GTPases are obvious candidate molecules. Evidence for the 
role of RhoA during ATP depletion in kidney epithelium comes from experiments 
utilizing the constitutively active Rho mutant, RhoV14. When RhoV14 is microinjected 
into tissue culture cells derived from renal proximal tubule epithelium before ATP 
depletion, cortical actin and stress fibers are maintained during subsequent depletion (33). 
Conversely, when the bacterial toxin C3 transferase, which specifically inactivates Rho, 
is injected stress fibers are not reassembled during recovery from ATP depletion. 
RhoV14 also protects tight junctions against disassembly during ATP depletion (17), 
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while the corresponding constitutively active mutant of Rac, RacV12, protects adherens 
junctions (16). 
Additional evidence for altered activity of Rho GTPases during ischemia or 
nucleotide triphosphate depletion is furnished by altered regulation of cytoskeletal 
proteins known to be downstream targets of Rho GTPase signaling. For example, ezrin is 
a protein link between the plasma membrane and the actin cytoskeleton (1) that is 
regulated by RhoA. In normal proximal tubule epithelial cells ezrin is localized in 
microvilli and at sites of cell-cell contact (19,35). Ezrin binds to the cytoplasmic domain 
of the cell surface glycoprotein, CD44 (36) and the carboxy-terminus of ezrin binds to 
actin (37). The interaction of ezrin and CD44 is of high affinity only in the presence of 
phosphatidylinositol 4,5-bisphosphate (21). RhoA is thought to regulate this interaction 
through its effector, phosphatidylinositol 4-phosphate 5-kinase (29). Another effector of 
RhoA, Rho kinase (ROK), phosphorylates ezrin in vitro (28). The dephosphorylation of 
ezrin is an early event during ischemia in renal epithelium (8). As a result of 
dephosphorylation, ezrin dissociates from the cytoskeleton and can be extracted with 
non-ionic detergents.  
The intracellular concentration of GTP is tightly coupled to that of ATP, and the 
two decrease in tandem with ischemia or chemical anoxia (10). Given the evidence for 
involvement of Rho GTPase signaling and the paucity of data concerning the effect of 
intracellular GTP levels on Rho protein signaling mechanisms in vivo, we used the ability 
of the GTPase binding domains from Rho effectors to discriminate between the GTP- and 
GDP-bound forms of the GTPase (24) to measure the relative amount of active and 
inactive RhoA, Rac1 and Cdc42 during ATP depletion induced by treatment with the 
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mitochondrial poison antimycin A combined with substrate depletion. We measured ATP 
and GTP levels in parallel with these assays, to establish the degree of correlation 
between the activation state of the GTPase and nucleotide levels in the cell. We also 
followed the localization of actin stress fibers and the detergent solubility of ezrin, during 
nucleotide triphosphate depletion and recovery. Finally, we measured the activity of 
RhoA, Rac1 and Cdc42 during nucleotide depletion and recovery in the presence of 
constitutively active RhoAL63. 
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Materials and Methods 
Chemicals.  All chemicals are from Sigma Chemical Co., St Louis, MO unless 
otherwise stated. 
Cell culture.  LLC-PK10 porcine proximal tubule cells were grown with KP 
medium (1:1 DMEM/Ham’s F-12 medium supplemented with 100 IU/ml penicillin, 100 
µg/ml streptomycin, 14 mM NaHCO3, and 12.5 mM HEPES) with 10% fetal bovine 
serum in a humidified chamber (95% air-5% CO2) at 37˚C. Cells were grown in collagen 
coated T-25 flasks (Techno Plastic Products, Switzerland). Cells were grown two days 
post-confluence and rinsed with warm PBS before use. To model ischemia, cells were 
incubated with depleted DMEM (medium without amino acids, glucose, serum and 
antibiotics) and 100 nM antimycin A. If recovery of these cells was required, they were 
rinsed with warm PBS and incubated with supplemented KP medium. For some 
experiments cells were rinsed twice and incubated with serum-free normal growth 
medium to control for the effect of removing growth factors. We analyzed the effect of 
ATP depletion in quiescent cells by incubating cells in serum-free medium for 24 hours 
prior to the experiment.  
Nucleotide triphosphate assay.  Cell cultures were rinsed three times with ice-cold 
PBS, scraped with 300µl of ice-cold acetonitrile followed by 700µl of ice-cold water (2) 
The extract was centrifuged at 16,000g for 10 minutes at 4˚C. The supernatant was 
gassed with N2 while on ice for 30 minutes to evaporate the acetonitrile. The residue was 
solubilized with 1N NaOH and the protein concentration determined by Coomassie blue 
assay (Pierce Chemical, Rockford, IL). To separate nucleotide triphosphates, samples 
were diluted 1:1 and 100µl was injected onto a 4-µm Nova-Pak C18 HPLC cartridge 
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(100 X 8 mm I.D.) equipped with a radial compression chamber (Waters, Milford, MA). 
The elution buffer consisted of 20% acetonitrile, 10mM ammonium phosphate and 2mM 
PIC Reagent A ion-pairing reagent (Waters, Milford, MA). The column was run 
isocratically at 2 ml/min (18) on a Hewlett Packard Chemstation model 1100 with UV 
detection at 254nm (Hewlett-Packard, Wilmington, DE). Internal standards showed that 
nucleotide recovery was greater than 90%.  
Visualization of stress fibers.  Cells were plated on collagen-coated coverslips in 
35 mm Petri dishes. Cells were treated with antimycin A as previously described. After 
the depletion time course, coverslips were fixed in PBS / 5% formaldehyde, 
permeabilized with PBS plus 0.2% Triton X-100 and incubated with 0.66µM rhodamine 
phalloidin (Molecular Probes, Eugene, OR). Confocal images were collected with a Zeiss 
Axiovert LSM510.  
GTPase activity assay. The Rho kinase Rho binding domain (ROK-BD, amino 
acids 941-1075) and the Pak (p-21 associated kinase) binding domain (Pak-BD, amino 
acids 67-150) cloned into pGEX vectors were transformed into E. coli strain, BL21. 
pGEX-ROK-BD was a kind gift from Dr. Kozo Kaibuchi (Nagoya University, Japan) 
(27) and pGEX-Pak-BD was a kind gift from Dr. Gary Bokoch (Scripps Research 
Institute, La Jolla, CA) (4). Production of the fusion protein was initiated with isopropyl 
β-D-thioglactopyranoside (IPTG). The fusion protein was isolated by binding to S-
hexylglutathione-agarose as described in the manufacturers instructions. The glutathione 
S-transferase (GST) fusion proteins bound to glutathione agarose (GST-ROK-BD and 
GST-Pak-BD) were stored in aliquots in liquid nitrogen for no more than one month. The 
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amount of fusion protein required to capture all of the available GTPase was determined 
empirically. 
Affinity isolation was carried out as described (5) with modifications. After 
treatment with antimycin A cells were rinsed with warm PBS. 350µl of buffer A [25mM 
Tris pH 7.5@4˚C, 150mM K acetate, 5mM EDTA, 5mM EGTA, 10mM dithiothreitol 
(DTT), 1% Triton X-100, 60mM n-octyl β-D-glucopyranoside (OG), 50µM butylated 
hydroxy toluene (BHT), 1mM phenyl methyl sulfonyl fluoride (PMSF), 1mM 
benzamidine, 2µg/ml aprotinin (Roche Molecular Biochemicals, Indianapolis, IN), 
1µg/ml Pepstatin A (Roche Molecular Biochemicals, Indianapolis, IN), 50µg/ml 
Leupeptin (Peptides International, Osaka, Japan), 40µg/ml Bestatin (Roche Molecular 
Biochemicals, Indianapolis, IN)] was added to the T25 flasks and incubated on ice for 10 
minutes with periodic manual rocking to evenly distribute the extraction buffer. The 
buffer was removed and centrifuged briefly at 15,000g. 25µl of detergent extract was 
mixed with 30µl of GST-ROK-BD to assay for RhoA activity, or 15µl of GST-Pak-BD 
to assay for Rac1 or Cdc42 activity, and incubated at 4˚C for 1 hour on a rotator.  The 
GST-binding domain was rinsed 3 times with 500µl of buffer A without detergent or 
protease inhibitors. This unbound fraction was precipitated with 10% trichloroacetic acid, 
rinsed with 70% ethanol, acetone, dried and dissolved in SDS sample buffer (50mM Tris 
7.5, 2% sodium dodecyl sulfate (SDS), 5% βME (beta mercaptoethanol), 6M urea, 
bromophenol blue). The bound fraction was dried in a vacuum and solubilized in SDS 
sample buffer. Bound and unbound fractions for each time point were run on a 15% SDS 
PAGE polyacrylamide gel (Biowhittaker Molecular Applications, Rockland, ME). This 
was followed by western blotting and immunostaining with 1µg/ml anti-RhoA antibody 
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(26C4, Santa Cruz Biotechnology, Santa Cruz, CA), 2µg/ml anti-Rac1 antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA) or 2µg/ml anti-Cdc42 antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA) and horseradish peroxidase conjugated anti-mouse 
secondary antibody (Jackson Immunoresearch, West Grove, PA). Blots were visualized 
with ECL (Amersham Pharmacia Biotech, Piscataway, NJ) and Biomax ML film (Kodak, 
Rochester, NY). To determine the ratio of bound to unbound GTPase, film images were 
digitized and the optical density of each band was quantified using a Fluor-S MultiImager 
with Quantity One 4.1 software (Biorad Laboratories, Hercules, CA). 
For assay validation experiments the detergent lysate was incubated with 1mM 
GDP, 1mM GTPγS or without additional nucleotide for 10 minutes at 30˚C. As a control 
for non-specific binding to GST a sample of lysate was incubated with glutathione-
agarose-GST.  
To ensure the validity of using a ratio of bound to unbound GTPase to express 
activity, the levels of the GTPases were measured by densitometry of immunoblots of 
whole cell extracts and normalized to the total amount of protein in LLC-PK10 cell 
lysates. When expressed as GTPase per µg of total protein for each of three time points, 0 
and 90 minutes of nucleotide triphosphate depletion and 90 minutes followed by 60 
minutes of repletion, there was no significant change in GTPase (RhoA, Rac1 and 
Cdc42) concentration during the time course of the experiment (data not shown).  
Ezrin solubility assay.  The solubility of ezrin during depletion and recovery was 
determined using the lysates from the RhoA activity assay. The amount of ezrin in the 
detergent insoluble fraction left after making the lysate was determined by adding SDS 
sample buffer to the T-flask containing the detergent insoluble adherent cell layer and 
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heating it to 80˚C for 2 minutes. The viscous solution was scraped out, sonicated to 
reduce the viscosity and run with the detergent soluble fractions on a 12% PAGE gel. 
Immunoblotting was performed using an anti-ezrin polyclonal antibody (kind gift of Jing 
Chen, Indiana State University, Terre Haute, IN) (9). Visualization and quantification 
were as described above. 
To demonstrate the effect of the RhoA signaling pathway on ezrin detergent 
solubility, 10µM of the Rho kinase inhibitorY27632 (11) (Upstate Biotechnology, Lake 
Placid, NY) was incubated with cells during recovery from depletion (as above) and the 
ezrin detergent solubility determined as described above.  
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Results
Nucleotide changes during ATP depletion and recovery.  Glucose depleted 
medium plus 100nM antimycin A was used to induce chemical anoxia in LLC-PK10
porcine proximal tubule epithelial cells, as a model of ischemic ATP depletion. The 
relative amount of ATP and GTP were determined by HPLC over the time course for 
which Rho GTPase activity was also measured (10). The reduction of ATP was rapid 
(Fig. 1A). Within 5 minutes ATP was almost reduced in half to 52%, ± 17% of the level 
in control cells. After 10 minutes of depletion, ATP was reduced to 28%, ±10.3% and 
reached a minimum of 1%, ±0.4% of the control value after 60 minutes. The change in 
GTP followed similar kinetics (Fig. 1B). Within 5 minutes GTP was reduced to less than 
half, i.e., 62.6 %, ±20.3% of the control value. After 10 minutes of depletion, GTP was 
42.4%, ±10.8% and reached a minimum of only 5.8%, ±3.4% of the control value after 
60 minutes. In addition to a higher relative minimum amount of GTP during ATP 
depletion conditions, GTP levels recovered more quickly than ATP when the cells were 
returned to normal growth conditions. GTP levels reached 86.2%, ±9.4% of the control 
value after 60 minutes of recovery in normal medium, while ATP reached only 42.1%, 
±9.1% of the control level after 60 minutes of recovery.  
Stress fiber integrity during depletion and recovery. The actin cytoskeleton is 
remodeled during ATP depletion (16,17,30). Actin stress fibers are regulated by RhoA 
and found near the basal membrane in LLCPK10 cells (33). During the time course over 
which we measured ATP and GTP levels, we followed the integrity of stress fibers by 
labeling F-actin with rhodamine phalloidin (Fig. 2). Normal stress fibers (Fig. 2, 0 
minutes) began to break down within 5 minutes after starting antimycin A treatment and 
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became progressively more punctate (Fig. 2, 5-90 minutes). After repletion of ATP with 
incubation in normal medium, stress fibers progressively reorganized (Fig. 2, 90/30 and 
90/60 minutes of depletion / repletion).
Measurement of RhoA Activity.  A fusion protein (GST-ROK-BD) consisting of 
glutathione-S-transferase (GST) and the effector-binding domain of human Rho kinase 
was used to selectively capture the GTP-bound form of RhoA with glutathione-agarose 
resin (24). Since only the GTP bound form of RhoA binds to the GST-ROK-BD, the 
active and the inactive proteins could be separated and detected by immunoblotting using 
anti-RhoA antibody (Fig. 3). We compared the active and inactive RhoA fractions in a 
control cell detergent lysate (Fig. 3A, lanes 1 and 2) and following 90 minutes of 
nucleotide triphosphate depletion (Fig. 3A, lanes 7 and 8). After 90 minutes of depletion, 
the amount of inactive RhoA increased and the amount of active RhoA decreased. The 
level of GTP-bound RhoA decreased substantially when the cell lysate was incubated 
with a large excess of exogenous GDP (Fig. 3A, lanes 3 and 4). Glutathione-agarose was 
incubated with GST as an additional control. Lanes 5 and 6 in figure 3A show that RhoA 
did not bind to GST-glutathione-agarose non-specifically. Additionally, after 90 minutes 
of nucleotide depletion, excess exogenous GTPγS (Fig. 3A, lanes 9 and 10) but not GDP 
(Fig. 3A, lanes 11 and 12) shifted the balance back towards the active form of RhoA.  
Since removal of the growth factors present in the normal growth medium could 
affect the activity of RhoA independently of ATP depletion, we tested the effect of 
removing serum on RhoA activity in control cells not subjected to ATP depletion, and the 
effect of the presence or absence of serum during the repletion phase. As shown in figure 
3B, the presence or absence of serum during the assay did not affect RhoA activity 
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significantly, although in the absence of serum RhoA activity levels during recovery were 
slightly lower than those observed with serum present. Serum starvation for 24 hours 
(Fig. 3C) did not significantly alter RhoA activity in these cells, nor did it alter the affect 
of nucleotide triphosphate depletion.  
Following the same time course of stress fiber disruption seen in figure 2, RhoA 
activity during nucleotide triphosphate depletion and repletion with normal medium is 
illustrated in figure 4A. Control cells (Fig. 4A, lanes 1 and 2) showed that a large fraction 
of RhoA was active (bound) in a confluent LLC-PK10 cell culture. During the time course 
of nucleotide triphosphate depletion (Fig. 4A, lanes 3-12) the amount of active RhoA 
decreased. Upon repletion of ATP levels with normal medium the level of active RhoA 
increased (Fig. 4A, lanes 13-16). The average of three experiments expressed as a ratio of 
bound protein (active) to unbound protein (inactive) is shown in Fig. 4B. A significant 
loss of RhoA activity was detected after as little as 5 minutes of nucleotide triphosphate 
depletion, by which time the activity ratio dropped to 46.2, ±15.1%. After 10 minutes of 
nucleotide triphosphate depletion the activity ratio dropped to 11.4 %, ±8.2 of the control 
value. No measurable RhoA activity was detected at 60 minutes of nucleotide 
triphosphate depletion. Upon repletion with normal medium, the ratio recovered to 
83.9%, ±78.9 of the control value by 30 minutes.  
Measurement of ezrin detergent solubility.  To determine whether alterations in 
the amount of activated RhoA during ATP depletion and recovery were reflected in the 
behavior of a known cytoskeletal target of Rho signaling, we followed the detergent 
solubility of the ERM (ezrin, radixin, moesin) protein ezrin as an indication of its 
association with the actin cytoskeleton during the time course of nucleotide depletion and 
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repletion (Fig. 5A). The control detergent fractionation of ezrin (0 minutes) shows that 
under our conditions much of the protein was recovered in the detergent soluble fraction 
but a significant fraction remained in the detergent insoluble fraction (Fig. 5A, lanes 1 
and 2). With nucleotide triphosphate depletion (Fig. 5A, lanes 3-12) the amount of ezrin 
in the detergent insoluble fraction decreased, suggesting that ezrin had dissociated from 
the cytoskeleton. As the cells recovered from depletion (Fig 5A, lanes 13-16), the amount 
of detergent insoluble ezrin increased. An average detergent solubility for ezrin during 
the time course (n=3) was expressed as the ratio of detergent insoluble to soluble ezrin. 
The detergent insolubility of ezrin decreased 60% during nucleotide triphosphate 
depletion and increased to control level after 30 minutes of repletion with normal 
medium (Fig. 5B), and showed an overall time course similar to that of RhoA activity 
with depletion and repletion (Fig. 4B).  
The serine/threonine kinase Rho kinase (or ROCK) is activated by binding to 
RhoA-GTP and phosphorylates ezrin among other targets (28). In order to demonstrate 
the effect of RhoA signaling on ezrin detergent solubility, we incubated the Rho kinase 
inhibitor Y27632 (11) with LLC-PK10 cells during nucleotide triphosphate depletion and 
repletion. Figure 5C shows a western blot of a typical experiment. In control cells a 
substantial amount of ezrin was associated with the cytoskeleton in the detergent 
insoluble fraction (lanes 1 and 2). Following 90 minutes of depletion, ezrin dissociated 
from the cytoskeleton and a decreased amount was found in the detergent insoluble 
fraction (lanes 3 and 4). However, with 60 minutes of repletion in normal medium, (lanes 
5 and 6) ezrin was again associated with the cytoskeleton in the insoluble fraction. When 
Y27632 was included in the incubation medium, ezrin failed to re-associate with the 
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cytoskeleton after 60 minutes of repletion, suggesting that Rho kinase, and therefore 
RhoA signaling, is important for the stable association of ezrin with the cytoskeleton. 
Activity measurement of Cdc42 and Rac1.  The depletion of nucleotide 
triphosphates likely affects the activity of the other Rho family GTPases as well as RhoA 
itself. We measured the activity of Cdc42 and Rac1 with a similar pull-down assay using 
a fusion of GST to the effector domain of Pak (containing the CRIB domain) to 
selectively bind GTP-bound Rac1 and Cdc42. To validate the assay, nucleotides were 
added to detergent extracts of LLC-PK10 cells to change the activity of the GTPases (Fig. 
6A). Without exogenously added nucleotides (Fig. 6A, lanes 1-2) most of Rac1 and 
nearly all of Cdc42 was found in the bound (active) lane. The addition of GDP increased 
the amount of GTPase in the unbound (inactive) fraction for both Cdc42 and Rac1. GST 
alone (Fig. 6A, lanes 5 and 6) did not pull-down any GTPase. When the cells were first 
depleted for 90 minutes with antimycin A, Cdc42 did not show any significant decrease 
in its activity. The level of active Rac1 was decreased after 90 minutes of depletion, but a 
significant fraction of GTP-bound Rac1 remained (Fig. 6A, lanes 7 and 8). Incubation 
with GTPγS increased the amount of GTPase in the active fraction for both proteins (Fig. 
6A, lanes 9 and 10). Addition of GDP decreased the total amount of Cdc42 that was 
recovered, making it impossible to determine the effect of GDP on the activity of Cdc42 
in this in vitro assay. GDP decreased the amount of active Rac1 (Fig. 6A, lanes 11 and 
12). We tested whether serum deprivation contributed to the effects we observed. 
Substituting serum free medium for normal growth medium, without induction of ATP 
depletion (Fig. 6B, lanes 1-4) did not affect Rac1 or Cdc42 activity, nor did it alter the 
effect of ATP depletion (Fig. 6B, lanes 5 and 6). Serum starvation (24 hours) had no 
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appreciable effect on Rac1 activity, but did result in a decrease in Cdc42 activity (Fig. 6C 
lanes 1 and 2). However, Cdc42 and Rac1 maintained high levels of activity after 90 
minutes of ATP depletion, even with prior serum starvation (Fig 6C, lanes 9 and 10).  
Since, in contrast to our results with RhoA (Fig. 3, lanes 7 and 8 and Fig. 4), there 
was no significant decrease in the amount of active Cdc42 and Rac1 with depletion we 
sought to demonstrate that the GTPase assay was capable of detecting physiological 
changes in the activity of Rac1 and Cdc42 in LLC-PK cells. Since cadherin mediated 
cell-cell adhesion has been shown to result in alterations in Rho GTPase activity (32), the 
activities of RhoA, Rac1 and Cdc42 were assayed using the pull-down assay 24 hours 
after seeding LLC-PK10 cells at a range of different densities. A representative western 
blot is shown in figure 7A. RhoA activity increased more than 36-fold from the lowest to 
the highest initial cell density (graphed in figure 7B), while Rac1 and Cdc42 activity 
decrease by 91.1%, ±6.5% and 85.2%, ±14.7% respectively. These experiments showed 
that our assay conditions were sufficiently sensitive to have detected physiological 
changes in the activity of all three GTPases during ATP depletion and recovery. 
A comparison of the changes in the activity of RhoA, Rac1 and Cdc42 during 90 
minutes of nucleotide triphosphate depletion and depletion, followed by 60 minutes of 
repletion in normal medium is shown in figure 8A. Under normal culture conditions (t=0) 
in post-confluent cultures all three GTPases were active (B, bound fraction). While RhoA 
was completely inactive after 90 minutes of depletion (U, unbound fraction), Rac1 was 
still active and Cdc42 activity had changed negligibly. A more complete time course of 
nucleotide triphosphate depletion and repletion for Rac1 activity revealed that Rac1 
activity dropped after initiation of depletion to a minimum at 30 minutes, but rebounded 
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to higher levels after 60 and 90 minutes (Fig. 8B). With repletion Rac1 activity increased 
to control levels after 30 minutes.  
The increase in Rac1 activity after an initial decrease during depletion raised the 
possibility that Rac1, RhoA or Cdc42 activity may fluctuate over a longer time course. 
However, a time course extended to 240 minutes of nucleotide triphosphate depletion 
showed that the activity of each of the three GTPases was relatively constant over longer 
time periods. RhoA activity remained near zero, Rac1 activity remained steady during 90 
to 240 minutes of depletion and Cdc42 remained almost entirely in the active state (Fig. 
9).
Effect of activated RhoA during depletion.  Considerable evidence exists for cross 
talk between the activities of different Rho family GTPases (22). Since RhoA activity 
decreases so rapidly with nucleotide depletion we considered that this might affect the 
activity of Rac1 or Cdc42. To test this possibility, the constitutively active RhoA mutant 
RhoAL63 was transfected into LLC-PK10 cells. Subsequently, nucleotide triphosphate 
depletion was induced with antimycin A and the activities of RhoA, Rac1 and Cdc42 
were measured after 90 minutes of depletion and after depletion followed by 60 minutes 
of repletion. No effect was found on the activity of endogenous RhoA or Cdc42 (data not 
shown). However, the ratio of active to inactive Rac1 decreased 32.1% during repletion, 
in the presence of RhoAL63 compared to untransfected controls. However, this change 
did not reach statistical significance (n=3, P=0.189).  
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Discussion
We demonstrate in this report that chemically induced anoxia in a cultured cell 
line derived from renal proximal tubule results in rapid conversion of RhoA-GTP to 
RhoA-GDP, with a time course that parallels the decrease in ATP and GTP levels. 
Repletion of ATP and GTP resulted in corresponding reversal of this effect and 
increasing levels of RhoA-GTP. The kinetics of RhoA inactivation and re-activation 
during ATP depletion and repletion were consistent with the cytoskeletal association of 
the known RhoA effector ezrin through depletion and repletion, which we show here and 
which is consistent with previous reports (8,9). We used the Rho kinase inhibitor Y27632 
to show the importance of RhoA signaling and the specific effect of Rho kinase inhibition 
on ezrin cytoskeletal association. In these experiments, Y27632 prevented the re-
association of ezrin with the cytoskeleton during ATP repletion. Myosin II regulatory 
light chain phosphorylation, another downstream target of RhoA signaling, also changes 
during ATP depletion with kinetics consistent with the changes we observe in RhoA 
activity (34). This pattern of RhoA inactivation in ischemia is consistent with the finding 
that constitutively active RhoA mutants are able to protect components of the actin 
cytoskeleton and associated structures in the basal and lateral domains of the cell cortex 
against disruption during ATP depletion (17, 33), and confirms an important role for 
RhoA in the pathophysiology of ischemic injury in the kidney.  
In contrast to the effect of ATP depletion on RhoA, the activation state of Rac1 
and Cdc42 did not directly correlate with the level of ATP or GTP in the cell. We 
confirmed that our assay was sensitive to physiological changes in Rac1 and Cdc42 
activity by measuring large decreases in activity as cell density increased to confluence. It 
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is interesting to note that the changes we observed in RhoA, Rac1 and Cdc42 activity 
were in the opposite direction to those observed in similar experiments on cell density in 
another renal epithelial cell line, MDCK (32). This discrepancy is not necessarily 
surprising, since other work has shown that signaling pathways involving Rho GTPases 
differ between MDCK and LLC-PK cells (S. Gopalakrishnan, MAH, SJA and J.A. Marrs, 
in press). It should be noted that the assays we use here are valid as an indication of 
relative changes in GTPase activity that result from the manipulations we used to alter 
ATP levels or cadherin engagement, but cannot be used as an indication of whether the 
basal level of GTPase activity in these cells is high or low compared to studies in other 
cells by other investigators, due to the sensitivity of the assay to buffer conditions and 
other variables in the protocol used.  
Our assay showed that Cdc42 activity did not decrease during ATP depletion, 
while the level of active Rac1 initially declined, but later recovered somewhat, even as 
ATP and GTP levels were still falling. Disruption of actin cytoskeletal organization is 
not, therefore, attributable to a net decrease in the cellular level of Cdc42 activity, and 
cannot be related in a simple way to the level of Rac1 activity. It may be that the activity 
of Cdc42 and Rac1 is still an important factor in cytoskeletal disruption, but that this 
disruption results instead from an imbalance in the level of activity of these Rho 
GTPases. In the absence of detectable RhoA activity, continued Cdc42 and Rac1 activity 
might indeed be one of the causes of aberrant actin polymerization into F-actin 
aggregates in the center of the cell that characterizes ATP depletion in renal proximal 
tubule cells (31), as well as in other cell types, such as fibroblasts and endothelial cells 
(14,20). Actin monomers released by the destruction of normal cytoskeletal assemblies 
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following RhoA inactivation, and from the thymosin sequestered pool, could be induced 
to polymerize at nuclei provided by the activity of Rac1 and Cdc42 effectors such as 
cortactin (38,41).  
The partial recovery of Rac1 activity at later times during ATP depletion, when 
ATP and GTP levels are still falling, is surprising. Since in many cell types RhoA activity 
antagonizes that of Rac1 (23,39), we considered that the nearly complete inactivation of 
RhoA could explain the partial recovery of Rac1. However, the constitutively active 
RhoA mutant RhoAL63 had no effect in Rac1 activity under ATP depleted conditions, so 
the signaling relays that normally operate between the two GTPases appear to be 
disrupted by ATP depletion, but are again operable during repletion.  
Under the conditions used here for ATP depletion, cellular ATP levels decrease to 
about 1% of the level in control cells, while the levels of GTP decrease to a minimum of 
5.8% of control levels. Assuming that the normal concentrations of ATP and GTP in our 
LLC-PK10 cells are comparable to other cell types (26), this corresponds to a decrease in 
ATP concentration from 2-5 mM to 20-50 µM, and a decrease in the GTP concentration 
from ~300 µM to ~17 µM. These GTP concentrations still significantly exceed the 
affinity constants of the GTPases for GTP. RhoA, Rac1 and Cdc42 GTPases’ affinities 
for GTP are comparable (KD~0.2 µM), as are their slightly lower affinities for GDP 
(KD~0.5-0.6 µM) (43). Exchange factors (GEFs) act by increasing the dissociation rate 
constant for bound nucleotide, so that in normal cells the cytoplasmic excess of GTP over 
GDP ensures that when GEFs bind the result is formation of the GTP-bound form of the 
protein. Under depleted conditions, however, GDP is in excess over GTP (at least over 
the short time scales as used here), and the activity of exchange factors could be expected 
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to result in inactivation of Rho proteins, since the relative affinities for GTP and GDP do 
not bias the exchange reaction sufficiently to prevent this. This may well be what 
happens to RhoA since the rapid kinetics of RhoA inactivation that we observe would be 
hard to account for by the intrinsic dissociation or hydrolysis rates, and must therefore 
result from the action of GEFs or GAPs. A role for regulatory proteins also seems to be 
required in view of the very different behavior of RhoA, Rac1 and Cdc42. If alterations 
in Rho protein activity were simply the result of their equilibration to the ambient 
GTP:GDP ratio in the cytoplasm one would expect to see the same effect of ATP 
depletion on all three GTPases, since their nucleotide affinities, dissociation rates and 
hydrolysis rates are comparable. That the effect of ATP depletion is so different for each 
protein argues that depletion selectively impacts the regulation of upstream pathways that 
control the activities of the GEF and GAP proteins. These upstream pathways may still 
directly sense the GTP:GDP or ATP:ADP ratio, but could transduce the effects of 
alterations in these ratios differentially to each Rho family member. Since it is generally 
accepted that GAP proteins are more promiscuous and GEF proteins more specific, it is 
reasonable to suppose that the differences in the effects of ATP depletion on RhoA, Rac1 
and Cdc42 result from different effects on specific GEF proteins.  
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Figure legends 
Fig. 1.  Nucleotide triphosphate levels during depletion and recovery measured by HPLC. 
Values are means ± SD, n=3. Cells were treated with antimycin A (0.1 µM) and substrate 
depleted media for the indicated times (5, 10, 30, 60 and 90 minutes) to induce depletion, 
or depleted for 90 minutes and returned to normal media for 30 or 60 minutes (90/30, 
90/60) A: Change in ATP level as a percentage of the control (0 minutes). B:
Corresponding values for GTP.  
Fig. 2.  Effect of nucleotide triphosphate depletion on stress fiber morphology. Confocal 
fluorescence micrographs show LLC-PK10 cells stained with rhodamine phalloidin to 
label filamentous actin. Cells were treated with antimycin A and substrate depleted 
medium for 0, 5, 10, 30, 60 and 90 minutes, or treated for 90 minutes and returned to 
normal medium. Magnification is 100X.  
Fig. 3.  Western blot showing assay for RhoA activity.  A. LLC-PK10 cells were 
incubated for 0 or 90 minutes with antimycin A and substrate depleted medium. The 
indicated nucleotides were added to some lysates, and all lysates were then incubated 
with GST-ROK-BD or GST alone (indicated) and separated into bound fraction (B), 
containing RhoA-GTP or unbound fraction (U), containing RhoA-GDP by incubation 
and centrifugation with glutathione agarose resin. Each fraction was analyzed by western 
blotting with an anti-RhoA antibody. B. Comparison of RhoA activity with serum present 
in the control (time 0, lanes 1 and 2) or with serum removed for 90 minutes (lanes 3 and 
4), and effect of ATP repletion in the presence (lanes 7 and 8) and absence (lanes 9 and 
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10) of serum. C. Cells were serum starved for 24 hours prior to ATP depletion (serum 
starvation) or fed with fresh serum containing medium 24 hours prior to the experiment 
(no starvation).
Fig. 4.  Effect of depletion and recovery on RhoA activity.  A. LLC-PK10 cells were 
incubated with antimycin A for various lengths of time or incubated with antimycin A for 
90 minutes followed by recovery in normal medium for 30 or 60 minutes. Detergent 
lysates were then incubated with GST-ROK-BD and separated into bound (B), containing 
RhoA-GTP or unbound (U), containing RhoA-GDP fractions by incubation and 
centrifugation with glutathione agarose. B. Graph of three experiments as represented in 
A. The amount of RhoA in each fraction was quantified by densitometry of western blots 
and expressed as the mean ratio, ± S.D., of bound to unbound as a percentage of the 
control (t=0) value.  
Fig. 5.  Effect of depletion and recovery on cytoskeletal association of ezrin.  A. LLC-
PK10 cells were incubated with antimycin A for various lengths of time or incubated with 
antimycin A for 90 minutes followed by recovery in normal medium for 30 or 60 
minutes. After detergent lysates (S) were made for the RhoA activity assay (Fig. 4), the 
detergent insoluble fractions were solubilized with SDS (I) and analyzed by western blot 
using an anti-ezrin polyclonal antibody. B. Graph of three experiments as represented in 
A. The amount of ezrin in each fraction was quantified by densitometry of the western 
blots and expressed the mean ratio, ± S.D., of detergent insoluble to detergent soluble 
ezrin. C. Western blot showing a typical experiment of the effect of the Rho kinase 
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inhibitor Y27632 on ezrin detergent solubility during recovery from ATP depletion. 
LLC-PK10 cells were incubated with antimycin A for 0 or 90 minutes or 90 minutes with 
60 minutes of repletion with or without Y27632. (S) is detergent soluble and (I) detergent 
insoluble ezrin. 
Fig. 6.  Western blot showing assay for Cdc42 and Rac1 activity.  LLC-PK10 cells were 
either incubated for 0 or 90 minutes with antimycin A. Detergent lysates were incubated 
with the indicated nucleotides. All lysates were then incubated with GST-Pak-BD or GST 
alone (indicated) and separated into bound (B), containing GTP-bound or unbound (U), 
containing GDP-bound GTPase fractions by incubation and centrifugation with 
glutathione agarose. Rac1 and Cdc42 in the bound and unbound fractions were detected 
using specific antibodies. B. Comparison of Rac1 and Cdc42 activity with serum present 
in the control (time 0, lanes 1 and 2) or with serum removed for 90 minutes (lanes 3 and 
4), and effect of ATP repletion in the presence (lanes 7 and 8) and absence (lanes 9 and 
10) of serum. C. Cells were serum starved for 24 hours prior to ATP depletion (serum 
starvation) or fed with fresh serum containing medium 24 hours prior to the experiment 
(no starvation). 
Fig. 7.  Effect of increasing cell density on the activities of RhoA, Rac1 and Cdc42. A.
LLC-PK10 cells were plated at cell densities increasing in a geometric progression by a 
factor of two. After 24 hours, activity assays (n=3) were performed for each GTPase. 
Bound (B), contains GTP-bound and unbound (U) contains GDP-bound GTPase. B.
Western blots were quantified by densitometry. The activities are expressed as the 
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percent change in the mean ratio, ± S.D., of bound to unbound GTPase between the ratios 
measured at the lowest and highest cell densities. 
Fig. 8.  A. Comparison of RhoA, Rac1 and Cdc42 activity assays. LLC-PK10 cells were 
treated with antimycin A and substrate depleted medium for 90 minutes or 90 minutes of 
antimycin A, followed by recovery in normal medium for 60 minutes. B. Effect of 
depletion and recovery on Rac1 activity. LLC-PK10 cells were incubated with antimycin 
A and substrate depleted medium for various lengths of time indicated or incubated with 
antimycin A for 90 minutes followed by recovery in normal medium for 30 or 60 
minutes. Detergent lysates were then incubated with GST-Pak-BD and separated into 
bound (B), containing GTP-Rac1 or unbound (U), containing GDP-Rac1 fractions by 
incubation and centrifugation with glutathione agarose. C. Graph of four experiments as 
represented in B. The amount of Rac1 in each fraction was quantified by densitometry of 
western blots and expressed as the mean ratio, ± S.D., of bound to unbound as a 
percentage of the control (t=0) value. 
Fig. 9.  Extended time course of GTPase activity. LLC-PK10 cells were treated with 
antimycin A for 0, 90, 180 or 240 minutes. The cells were lysed and GTPase activities 
were measured as described previously. 
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